Detalhe da pesquisa
1.
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.
Clin Gastroenterol Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729389
2.
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Aliment Pharmacol Ther
; 57(4): 426-434, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534763